Tradestie Institutional Equity Comparison Engine

CTRE vs XRN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CTRE Overall Edge

CTRE Captures Institutional Edge (4โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CareTrust REIT, Inc (CTRE) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CTRE trades at 19.7x Forward P/E with 66.2% operating margin (+33.2% YoY revenue) versus XRN at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, CTRE sits in CONSOLIDATION (11th %ile IV; Dealer Gamma Walls on Pro) against XRN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner CTRE
CTRE 19.7x vs XRN N/M Fwd P/E
Growth & Margin Winner CTRE
Op Margin 66.2% vs N/A ยท YoY +33.2% vs N/A
Momentum & Technical Winner CTRE
1Y +3.8% vs -28.2% ยท 52W Pos 28% vs 1%
Options & Structure Winner CTRE
CONSOLIDATION (11th %ile IV) vs UNCLASSIFIED (N/A IV)
CTRE NYSE
CareTrust REIT, Inc
Real Estate Investment Trusts
$37.23
-0.43% 1D
Market Cap $9.8B
1M Return +3.88%
1Y Return +3.76%
Forward P/E 19.7x
Unified AI Score
56.4 / 100 HOLD
Tech 47.0 Fund 54.0 Flow 57.0 Mom 60.0
XRN US Equity
XRN
Institutional Equity
$25.79
-2.35% 1D
Market Cap N/A
1M Return -13.02%
1Y Return -28.16%
Forward P/E N/M
Unified AI Score
45.3 / 100 HOLD
Tech 45.0 Fund 53.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CTRE +3.76% XRN -28.16% Spread: +20.09 pp (CTRE Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CTRE TTM Op. Margin: 66.2% XRN TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CTRE vs XRN. Trailing 12-month operating profitability (CTRE 66.2% vs XRN N/A) and valuation multiples (CTRE 19.7x vs XRN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CTRE (10) vs XRN (0)
Institutional Metric CTRE XRN Criterion Row Winner
Market Capitalization Scale $9.8B N/A Larger Scale CTRE
Trailing P/E Ratio Valuation 23.9x N/M Lower Multiple CTRE
Forward P/E Ratio Valuation 19.7x N/M Lower Multiple CTRE
Revenue Growth (YoY) Growth +33.2% N/A Higher Growth CTRE
Operating Margin (TTM) Profitability 66.2% N/A Higher Margin CTRE
Net Profit Margin Profitability 59.2% N/A Higher Margin CTRE
Return on Equity (ROE) Capital Efficiency 7.7% N/A Higher ROE CTRE
52-Week Range Position Momentum 28% ($35โ€“$44) 1% ($26โ€“$39) Stronger Trend CTRE
Beta / 30D Volatility Risk Regime 0.16ฮฒ ยท 28% Vol 0.50ฮฒ ยท 47% Vol Lower Realized Risk CTRE
Unified Institutional Score Composite Signal 56.4 / 100 (HOLD) 45.3 / 100 (HOLD) Higher Composite CTRE

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CTRE vs XRN Buy Guide
CTRE CONSOLIDATION
84d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live CTRE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
XRN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live XRN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CTRE nor XRN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.